Label: ONELAX SENNA- senna syrup
- NDC Code(s): 71399-0027-8
- Packager: Akron Pharma Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 10, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient
- Uses
-
Warnings
ask a doctor before use if you have • stomach pain • nausea • vomiting • noticed a sudden change in bowel movements that continues over a period of 2 weeks
Do not use laxative products for longer than 1 week unless directed by a doctor
Ask a doctor or pharmacist before use if
you are taking any other drug. Take this product two more hours before or after other drugs. Laxatives may affect how other drugs work.
- Directions
-
DOSAGE & ADMINISTRATION
age starting dose maximum dosage Adults and children 12 yeart and older 2-3 teaspoons once a day 3 teaspoons twice a day Children 6 years to under 12 yeart 1 - 1 1/2 teaspoons once a day 11/2 teaspoons twice a day Children 2 years to under 6 yeart l/2 - 3/4 teaspoon once a day 3/4 teaspoon twice a day Children under 2 years ask a doctor ask a doctor - Other Information
- Inactive Ingredients
- KEEP OUT OF REACH OF CHILDREN SECTION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ONELAX SENNA
senna syrupProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:71399-0027 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B 417.12 mg in 237 mL Inactive Ingredients Ingredient Name Strength METHYLPARABEN (UNII: A2I8C7HI9T) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) PROPYLPARABEN (UNII: Z8IX2SC1OH) WATER (UNII: 059QF0KO0R) SUCROSE (UNII: C151H8M554) Product Characteristics Color Score Shape Size Flavor CHOCOLATE Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:71399-0027-8 237 mL in 1 BOTTLE; Type 0: Not a Combination Product 02/06/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M007 02/06/2024 Labeler - Akron Pharma Inc. (067878881)